Skip to main content

Day: December 13, 2024

Laboratory Information System Market is to Grow at a CAGR of 10.90% By 2031 | SkyQuest Technology

The laboratory information system market growth is being positively affected by advancements in R&D laboratories, particularly in the biotechnological and pharmaceutical labs. Westford, USA, Dec. 13, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the global laboratory information system market share will reach a value of USD 5.33 Billion by 2031, with a CAGR of 10.90% during the forecast period (2024-2031). Due to technical advancements in pharmaceutical laboratories and growing demand for lab automation, the global laboratory information system market has witnessed tremendous growth over the past few years. The laboratory information system market growth is being positively affected by advancements in R&D laboratories, particularly in the biotechnological and pharmaceutical labs. Due to the ongoing R&D activities...

Continue reading

Automotive Active Seat Headrests Market to Surpass Valuation of USD 25.49 Billion by 2031 | SkyQuest Technology

Westford, USA, Dec. 13, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the global automotive active seat headrests market size will reach a value of USD 25.49 Billion by 2031, with a CAGR of 5.73% during the forecast period (2024-2031). As a result of the increased consumer education on car safety features, the impending global automotive active seat headrests market trends for safety technology, that is active seat headrests, may take shape. Growing consumer desire for safe and comfortable driving experiences may lead to a use of advanced safety features like active seat headrests. This information may drive the need for developments such as active seat headrests that specifically target and reduce the severity of whiplash injuries, which are common in rear-end incidents. Download a detailed overview: https://www.skyquestt.com/sample-request/automotive-active-seat-headrests-market...

Continue reading

Plymouth Industrial REIT Declares Dividend for the Fourth Quarter of 2024

BOSTON, Dec. 13, 2024 (GLOBE NEWSWIRE) — Plymouth Industrial REIT, Inc. (NYSE: PLYM) (the “Company”) today announced that its board of directors has declared a regular quarterly cash dividend of $0.24 per share of common stock for the fourth quarter of 2024. The dividend, which equates to an annualized rate of $0.96 per common share, is payable on January 31, 2025, to stockholders of record as of the close of business on December 31, 2024. About Plymouth Plymouth Industrial REIT, Inc. (NYSE: PLYM) is a full service, vertically integrated real estate investment company focused on the acquisition, ownership and management of single and multi-tenant industrial properties. Our mission is to provide tenants with cost effective space that is functional, flexible and safe. Contact:Tripp SullivanSCR PartnersIR@plymouthreit.com

Continue reading

AGF Management Limited Declares Fourth Quarter 2024 Dividend

TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) — On December 13, 2024, the Board of Directors of AGF Management Limited declared a dividend of 11.5 cents per share on both the Class B Non-Voting shares and the Class A Voting common shares of the company. This dividend will be payable on January 16, 2025 to shareholders of record on January 8, 2025. About AGF Management Limited Founded in 1957, AGF Management Limited (AGF) is an independent and globally diverse asset management firm. Our companies deliver excellence in investing in the public and private markets through three business lines: AGF Investments, AGF Capital Partners and AGF Private Wealth. AGF brings a disciplined approach, focused on incorporating sound, responsible and sustainable corporate practices. The firm’s collective investment expertise, driven by its fundamental,...

Continue reading

Form 8.3 – Aviva plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Jupiter Fund Management Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of Offeror in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Aviva plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date dealing undertaken:        For an opening position disclosure, state...

Continue reading

Sound Group Inc. Reports First Half of 2024 Unaudited Financial Results

SINGAPORE, Dec. 13, 2024 (GLOBE NEWSWIRE) — Sound Group Inc. (NASDAQ: SOGP) (“SOGP” or the “Company” or “We”), a global audio-centric social and entertainment company, today announced its unaudited financial results for the six months ended June 30, 2024. First Half of 2024 Financial and Operational HighlightsNet revenues were RMB924.0 million (US$127.1 million) for the six months ended June 30, 2024, compared with RMB1,223.8 million for the six months ended June 30, 2023. Net loss was RMB36.5 million (US$5.0 million) for the six months ended June 30, 2024, compared with net income of RMB59.9 million for the six months ended June 30, 2023. Average total mobile MAUs1 for the six months ended June 30, 2024 was 35.7 million, compared with 47.6 million for the six months ended June 30, 2023.Mr. Jinnan (Marco) Lai, Founder and CEO...

Continue reading

The Ensign Group, Inc. Increases Quarterly Dividend to $0.0625 Per Share

SAN JUAN CAPISTRANO, Calif., Dec. 13, 2024 (GLOBE NEWSWIRE) — The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it has declared a quarterly cash dividend of $0.0625 per share of Ensign common stock, payable on or before January 31, 2025, to shareholders of record as of December 31, 2024. “We are pleased to announce our twenty-second consecutive annual dividend increase, which reflects our strong market position and continued commitment to return value to our shareholders,” commented Barry Port, Ensign’s Chief Executive Officer. “We look forward to further growth in the upcoming...

Continue reading

Polyrizon Announces Appointment of VP of Regulatory Affairs and Quality Assurance

Raanana, Israel, Dec. 13, 2024 (GLOBE NEWSWIRE) — Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announces today the appointment of Asaf Azulay, the Managing Director of Eurofins’ Li-Med team, to its leadership as its VP of Regulatory Affairs and Quality Assurance (RA/QA). This strategic appointment reflects Polyrizon’s ongoing commitment to maintaining the highest industry standards as it advances its pipeline of cutting-edge solutions. Asaf Azulay brings over 20 years of extensive experience in the medical devices industry, with expertise in leading quality teams and implementing regulatory strategies. His deep understanding of the global regulatory landscape will play a vital role in...

Continue reading

The Board of Directors’ decision on a new execution strategy and prioritisation of clinical areas in Reponex Pharmaceuticals A/S.

          The Board of Directors’ decision on a new execution strategy and prioritisation of clinical areas in Reponex Pharmaceuticals A/S.    December 13, 2024Announcement No. 32   Pharma Equity Group conducts continuous evaluation of the clinical pipeline of Reponex Pharmaceuticals A/S (Reponex) based on a number of fundamental commercial criteria, including medical need, patient recruitment, regulatory requirements, likelihood of success and requirements for both human and monetary capital.Based on this evaluation, Reponex has chosen to give top priority to the following development programmes: RNX-051 for Colon Adenomas and Colon Cancer RNX-011 for the Treatment of Peritonitis RNX-041 for the treatment of IBD (pouchitis)The mentioned development programs have all shown relevant, informative...

Continue reading

U.S. Energy Corp. Announces Entry Into Binding Agreement For Sale Of East Texas Properties

HOUSTON, Dec. 13, 2024 (GLOBE NEWSWIRE) — U.S. Energy Corporation (NASDAQ: USEG, “U.S. Energy” or the “Company”) today announced that the Company has executed definitive documents for the sale of certain assets located in East Texas (the “East Texas Assets” and the “Transaction”). The Transaction is subject to customary closing conditions and the Transaction is expected to close on or before December 31, 2024. HIGHLIGHTSAll cash proceeds of $6,825,000. Proceeds are expected to be used to fund the continued development of U.S. Energy’s industrial gas project in Montana. Divested assets averaged approximately 1.1 million cubic feet per day of natural gas and 168 barrels of oil per day for the quarter ending September 30, 2024. Divested assets averaged approximately $136,000 per month of net cash flow at realized oil and gas commodity...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.